EFG Asset Management Americas Corp. Purchases 849 Shares of Axon Enterprise, Inc $AXON

EFG Asset Management Americas Corp. boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 32.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,473 shares of the biotechnology company’s stock after purchasing an additional 849 shares during the period. EFG Asset Management Americas Corp.’s holdings in Axon Enterprise were worth $2,875,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. TCI Wealth Advisors Inc. purchased a new stake in Axon Enterprise in the second quarter worth $214,000. Duncker Streett & Co. Inc. grew its holdings in shares of Axon Enterprise by 3.2% in the second quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company’s stock worth $12,006,000 after purchasing an additional 448 shares during the last quarter. EFG Asset Management North America Corp. increased its stake in Axon Enterprise by 17.8% in the 2nd quarter. EFG Asset Management North America Corp. now owns 12,701 shares of the biotechnology company’s stock worth $10,511,000 after buying an additional 1,918 shares during the period. New York Life Investment Management LLC lifted its holdings in Axon Enterprise by 3.2% during the 2nd quarter. New York Life Investment Management LLC now owns 11,044 shares of the biotechnology company’s stock valued at $9,144,000 after buying an additional 341 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in Axon Enterprise during the 2nd quarter valued at about $284,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON opened at $531.09 on Thursday. Axon Enterprise, Inc has a 12 month low of $469.24 and a 12 month high of $885.91. The stock has a fifty day moving average price of $690.64 and a 200-day moving average price of $733.23. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The firm has a market cap of $41.91 billion, a PE ratio of 131.13, a P/E/G ratio of 29.49 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. During the same period in the prior year, the business posted $1.45 EPS. Axon Enterprise’s revenue was up 30.6% compared to the same quarter last year. Equities research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analyst Ratings Changes

AXON has been the topic of a number of research analyst reports. Bank of America upped their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. UBS Group reduced their price objective on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Craig Hallum raised Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price for the company in a research report on Tuesday, August 5th. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. Finally, Northland Securities set a $800.00 price target on Axon Enterprise in a research note on Tuesday, August 5th. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $814.00.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer directly owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $743.64, for a total value of $7,436,400.00. Following the sale, the chief executive officer directly owned 3,043,982 shares in the company, valued at $2,263,626,774.48. This represents a 0.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 38,622 shares of company stock valued at $26,439,364. 4.40% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.